KRAS and pancreatic neoplasm: In fact, KRAS mutant colon tumors are demonstrated to be associated with an increased expression of glutamine and glycolytic metabolic proteins, while KRAS mutant pancreatic tumor showed reprogrammed glutamine metabolism [32].